Antimicrobial Susceptibility Testing Market Revenue, Growth Rate, Customer Needs, Trend, Manufacturers, and Forecast to 2030

Market Overview:

Antimicrobial susceptibility testing helps determine the susceptibility of bacterial and fungal isolates to antibacterial and antifungal agents respectively. This testing guides the clinicians in choosing effective antimicrobial therapies for treating infectious diseases.

Market Dynamics:

The antimicrobial susceptibility testing market is expected to witness significant growth over the forecast period owing to the rising prevalence of infectious diseases globally. As per the WHO, infectious diseases accounted for approximately 26% of global deaths in 2020. Additionally, growing antimicrobial resistance has further increased the necessity of AST to monitor the resistance patterns and guide effective treatment decisions. Furthermore, advancement in AST technologies such as molecular diagnostics and continuous monitoring solutions are also fueling the market growth.

Receive Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2449

** Note - This Report Sample Includes:

‣ Brief Overview to the research study.

‣ Table of Contents The scope of the study's coverage

‣ Leading market participants

‣ Structure of the report's research framework

‣ Coherent Market Insights' research approach

Major companies in Antimicrobial Susceptibility Testing Market are:

✤ Thermo Fisher Scientific Inc. and BIOMÉRIEUX
✤ HiMedia Laboratories
✤ Alifax S.r.l. Italy
✤ Creative Diagnostics
✤ Resistell AG
✤ Danaher
✤ Becton
✤ Dickinson and Company
✤ Merck KGaA
✤ Bio-Rad Laboratories Inc.
✤ Bruker
✤ Nissui Pharmaceutical Co., Ltd.,
✤ F. Hoffmann-La Roche Ltd.,Synbiosis
✤ Mast Group Ltd.
✤ ELITechGroup
✤ Flinn Scientific
✤ CONDALAB
✤ Accelerate Diagnostics Inc. and Zhuhai DL Biotech Co., Ltd.,

Note: Major Players are sorted in no particular order.

Rising Adoption of Advanced Antimicrobial Resistance Testing Methods

The antimicrobial susceptibility testing market is witnessing growing adoption of advanced testing methods like polymerase chain reaction (PCR), microarrays, next-generation sequencing (NGS), and mass spectrometry. PCR, microarrays, and NGS help identify genes responsible for antimicrobial resistance at a much faster rate compared to conventional methods. They can detect multiple pathogens and resistance genes in a single test, enabling clinicians to optimize antimicrobial treatment. Mass spectrometry techniques like matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) help identify microbes in a few hours compared to automated systems or biochemical methods that may take one to several days. The ability of these advanced methods to detect resistance rapidly and sensitively is a key driver boosting their uptake in the antimicrobial susceptibility testing market.

Increasing Prevalence of Hospital-Acquired Infections

The growing prevalence of hospital-acquired infections (HAIs) has emerged as a key factor propelling the demand for antimicrobial susceptibility testing solutions. HAIs tend to be more severe than community-acquired infections as hospital pathogens are frequently resistant to many standard antibiotics. They expose patients to potentially extended hospital stays and increase morbidity and mortality risk. Healthcare institutions are hence investing significantly in diagnostic capabilities to minimize HAIs. Rapid antimicrobial susceptibility testing helps clinicians prescribe the most effective antibiotics right from the onset. It improves patient outcomes while containing healthcare costs associated with longer hospitalization for treatment of resistant infections. As HAIs continue rising globally, driven by factors such as widespread antibiotic misuse, the need for robust diagnostic testing will remain elevated.

Stringent Regulatory Standards for Testing Validation

Obtaining regulatory approvals or clearances for new diagnostic tests has become increasingly difficult with evolving regulatory frameworks. Both the US FDA and EU have been tightening standards to establish adequate performance validation of tests for susceptibility to various antimicrobial drugs. Manufacturers must demonstrate analytical and clinical validity through well-planned studies and trials. Gaining regulatory approval is a long, complex, and expensive process. It entails extensive documentation and high investment in validating performance on multiple pathogen-antibiotic combinations. The regulatory challenges have made manufacturers reluctant to invest in the development and commercialization of novel testing platforms. Strict standards discourage the entry of small businesses and startup firms who lack resources for navigating stringent validation pathways. This acts as a deterrent to innovation in the antimicrobial susceptibility testing market.

Growing Personalized Medicine Needs

The thrust towards personalized treatment paradigms optimized for individual patients presents new opportunities in the antimicrobial susceptibility testing market. There is increasing focus on rapid diagnostics to facilitate precision antibiotic selection based on an individual's infection history, risk factors, pharmacogenetics, and genomic or resistance profiles. Coupled with epidemiological information, such tailored diagnostic data help optimize patient management and outcomes. Advanced molecular techniques enable detection of multiple resistance markers, virulence factors, and other pathobiofilm markers beyond standard culture-based methods, supporting new models of personalized care. Growing integration of diagnostics with digital health also allows sharing real-time testing data between clinicians, enabling networked, data-driven personalized treatment decisions. As personalized medicine gains ground, advanced antimicrobial susceptibility tests are likely to see expanding roles.

Shift to More Rapid and Automated Testing Methods

The conventional culture-based antimicrobial susceptibility testing practices are outdated and unable to meet current needs for faster, high-throughput precision diagnostics. There is a definite shift towards automated, non-culture based methods that enable generating antibiograms and sensitivity reports in hours instead of days. Several rapid diagnostic platforms have been introduced with capabilities like direct-from-specimen testing in 1-2 hours and high sample processing capacity. Emerging technologies such as microfluidics, nanotechnology, biosensors, artificial intelligence, and machine learning are enabling faster, easier, and more automated versions. Both established and emerging players are developing integrated, sample-to-result solutions with minimal hands-on time that can be adapted to laboratory as well as point-of-care settings. The market trend reflects an ongoing transformation to more rapid, automated, and decentralized diagnostic modalities suited to the current healthcare landscape.

Purchase Our Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2449

Highlights of the global Antimicrobial Susceptibility Testing Market report:

→ This analysis provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), using 2021 as the base year. It also covers the global Antimicrobial Susceptibility Testing Market in-depth.

→ It offers enticing investment proposition matrices for this sector and explains the likely future growth of key revenue streams.

→ Additionally, this study offers crucial insights into market forces, limitations, opportunities, new product introductions or approvals, market trends, regional perspective, and competitive tactics used by top rivals.

→ Based on the following factors: company highlights, product portfolio, significant highlights, financial performance, and strategies, it covers key players in the global Antimicrobial Susceptibility Testing Market.

→ Marketers and company leaders will be able to make wise decisions about next product launches, type updates, market expansion, and marketing strategies thanks to the insights from this research.

→ A wide spectrum of industry stakeholders are covered by the global Antimicrobial Susceptibility Testing Market research, including investors, vendors, product producers, distributors, new entrants, and financial analysts.

→ The many strategy matrices used in researching the global Antimicrobial Susceptibility Testing Market will aid stakeholders in making decisions.

The research was developed through the synthesis, analysis, and interpretation of data gathered from multiple sources on the parent market. Additionally, analysis has been done of the economic circumstances and other economic indicators and factors to evaluate their respective impact on the Antimicrobial Susceptibility Testing Market, along with the present impact, so as to develop strategic and informed projections about the scenarios in the market. This is mostly due to the developing countries' unmet potential in terms of product pricing and revenue collection.

Key Questions Answered In The Report:

• Which regional market will experience the greatest and most rapid growth?

• Who are the top five Antimicrobial Susceptibility Testing Market players?

• How will the Antimicrobial Susceptibility Testing Market evolve over the next six years?

• What application and product will dominate the Antimicrobial Susceptibility Testing Market?

• What are the market drivers and constraints for Antimicrobial Susceptibility Testing Market?

• What will be the Antimicrobial Susceptibility Testing Market's CAGR and size during the forecast period?

Get Customize Report! @ https://www.coherentmarketinsights.com/insight/request-customization/2449

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.